NCT07597759CompletedEarly phase 1
Phase IIT Trial of SNA009
A Clinical Study Evaluating the Safety, Tolerability, Biodistribution and Radiation Dose Measurement of 68Ga-NODAGA-SNA009 in Patients With Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
This clinical trial is a single-center, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics and radiation dosimetry of 68Ga-NODAGA-SNA009 in patients with colorectal cancer.
- Status (registry)
- Completed
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 21 Apr 2026
- Start date
- 30 Oct 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- SmartNuclide Biopharma
- Diseases
- Colorectal cancer
- NCT number
- NCT07597759
What you commit to
- Study type: Interventional · Early phase 1
- Participants enrolled: 12
- From 30 Oct 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with other clearly diagnosed malignant tumours;
- Patients with uncontrolled severe infections, or those with other serious comorbidities;
Other
- Patients with a life expectancy of ≤3 months;
- Pregnant or breastfeeding patients, and patients of childbearing potential who refuse to use appropriate contraception during the trial;
- Patients deemed unsuitable for participation in this study by the investigator.
Who the study is looking for
- Aged between 18 and 75 years (inclusive);
- Participants must have legal capacity, voluntarily agree to participate in this clinical trial, and have signed an informed consent form (ICF);
- Patients with a confirmed diagnosis of colorectal cancer;
- Results of colonoscopy, CT, MRI or PET-CT scans performed within the past month (if available);
- Pathology test results from within the past year
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tianjin Medical University Cancer Institute and Hospital Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.